Do not take ONGLYZA if you are allergic to any of its ingredients. Serious allergic reactions can occur with ONGLYZA and may include swelling of the face, lips or throat, difficulty swallowing or breathing, swelling of the skin, hives, rash, itching, flaking, or peeling. If you have these symptoms, stop taking ONGLYZA and contact your doctor right away.

Serious side effects can happen to people taking ONGLYZA, including inflammation of the pancreas (pancreatitis) which may be severe and lead to death. Before taking ONGLYZA, tell your doctor if you ever had pancreatitis, gallstones, history of alcoholism, or high triglyceride levels. Stop taking ONGLYZA and contact your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.

When ONGLYZA is used with certain other diabetes medicines to treat high blood sugar, such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is higher. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your doctor’s instructions for treating low blood sugar.

When ONGLYZA is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone, to treat high blood sugar, peripheral edema (fluid retention) may become worse. If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles, call your doctor.

The most common side effects with ONGLYZA include upper respiratory tract infection, urinary tract infection, and headache.

Your doctor should test your blood to measure how well your kidneys are working before and during treatment with ONGLYZA. You may need a lower dose if your kidneys are not working well.

Tell your doctor if you start or stop taking other medications, including antibiotics, antifungals or HIV/AIDS medications, as your doctor may need to change your dose of ONGLYZA.

Tell your doctor if you are pregnant, breast-feeding, or plan to become pregnant or breast-feed.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please click here for Medication Guide and click here for US Full Prescribing Information for
ONGLYZA (saxagliptin)

Before you start exploring, take the time to read and understand the Important Safety Information.

rollover to read more

Onglyza Savings Program

If your doctor has prescribed Onglyza for you, print or activate an Onglyza Value Card now and save on refills for up to a year**. Eligibility rules apply (see Terms and Conditions).

Print or activate your Onglyza Value Card**

The Onglyza Value Card Program offers eligible patients easy and instant savings:

  • Copay is no more than $10 per month for most eligible patients with commercial prescription coverage.
  • Savings are up to $100 per 30-day supply for eligible cash-paying patients

See Onglyza Value Card Program for Details and Eligibility.
** Eligibility rules apply. Bristol-Myers Squibb and AstraZeneca reserve the
right to rescind, revoke, or amend this offer at any time without notice.

IMPORTANT SAFETY INFORMATION for ONGLYZA (saxagliptin)

Do not take ONGLYZA if you are allergic to any of its ingredients. Serious allergic reactions can occur with ONGLYZA and may include swelling of the face, lips or throat, difficulty swallowing or breathing, swelling of the skin, hives, rash, itching, flaking, or peeling. If you have these symptoms, stop taking ONGLYZA and contact your doctor right away.

Serious side effects can happen to people taking ONGLYZA, including inflammation of the pancreas (pancreatitis) which may be severe and lead to death. Before taking ONGLYZA, tell your doctor if you ever had pancreatitis, gallstones, history of alcoholism, or high triglyceride levels. Stop taking ONGLYZA and contact your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.

When ONGLYZA is used with certain other diabetes medicines to treat high blood sugar, such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is higher. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your doctor’s instructions for treating low blood sugar.

When ONGLYZA is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone, to treat high blood sugar, peripheral edema (fluid retention) may become worse. If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles, call your doctor.

The most common side effects with ONGLYZA include upper respiratory tract infection, urinary tract infection, and headache.

Your doctor should test your blood to measure how well your kidneys are working before and during treatment with ONGLYZA. You may need a lower dose if your kidneys are not working well.

Tell your doctor if you start or stop taking other medications, including antibiotics, antifungals or HIV/AIDS medications, as your doctor may need to change your dose of ONGLYZA.

Tell your doctor if you are pregnant, breast-feeding, or plan to become pregnant or breast-feed.

Value Card Program Details and Eligibility

TO THE PATIENT:

Eligible patients with commercial prescription coverage whose co-pay (out-of-pocket expense) for a 30 day supply of Onglyza™ (saxagliptin) tablets is more than $10 can receive up to $100 in savings on each product. Savings not applicable to monthly out of pocket expenses of $10 or less. Eligible patients without commercial prescription coverage (cash-paying patients) will receive up to $100 in savings per 30 day supply of Onglyza. Offer valid for up to a total of 24 monthly fills, within 27 months, of Onglyza™, as prescribed. Not for concomitant use. Card is limited to 1 per patient for the life of the program and is not transferable. Bristol-Myers Squibb and AstraZeneca reserve the right to rescind, revoke, or amend this offer at any time without notice. Card activation is required. First use must take place by 2/28/12. Card expires on 5/31/14. Card is not an insurance card.

Eligibility: Valid for residents of the U.S. and Puerto Rico. Void in Massachusetts and where prohibited by law, taxed, or restricted. Card is not valid for prescriptions covered in full or in part by a state or federally-funded program including but not limited to Medicare, Medicaid, Medigap, Veterans Administration or Department of Defense, or where the entire cost of prescription is reimbursed by a health or pharmacy benefit program.

Patient: By using this card, you confirm that you agree to the terms of use and meet the eligibility criteria above.

FOR YOUR PHARMACIST:

By accepting this card and submitting a claim to the Value Card Program for Onglyza, you certify that the prescription is not being filled in Massachusetts and that the prescription is not covered in full or in part by any state or federally-funded program, including but not limited to Medicare, Medicaid, Medigap, VA or DOD. Submit transaction to McKesson Corporation using BIN #610524. If primary coverage exists, input card information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Applicable discounts will be displayed in the transaction response. Acceptance of this card and your submission of claims for the Value Card program for Onglyza are subject to the LoyaltyScript® program Terms and Conditions posted at http://www.mckesson.com/mprstnc. For questions regarding setup, claim transmission, patient eligibility or other issues, call 1-866-747-4958 (8:00 AM-8:00 PM EST, Monday-Friday).

Onglyza Value Card is a LoyaltyScript® program ISSUER: (80840)